Literature DB >> 29471688

Plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from urine clinical samples.

Orsolya Szabó1, Dániel Gulyás1, Nikolett Szabó1, Katalin Kristóf2, Béla Kocsis1, Dóra Szabó1.   

Abstract

Plasmid-mediated quinolone resistance (PMQR) determinants including, qnrA, qnrB, qnrC, qnrD, qnrS, aac(6')-Ib-cr, oqxAB, and qepA, were investigated in 214 Enterobacteriaceae strains from urine clinical samples. Antimicrobial susceptibility testing for ciprofloxacin, ceftriaxone, and imipenem was performed by broth microdilution method. All strains were screened for PMQR genes by PCR. Virulence determinants, namely afa, pap, pil, sfa/foc, and kpsMT of eight Escherichia coli strains proven positive for at least one qnr gene, were investigated by PCR. All of the eight investigated strains carried the pil gene, showing that P fimbria is a common virulence determinant among qnr positive E. coli. Out of 214 tested strains, 38 yielded any PMQR determinant, altogether 45 genes were detected namely, 6 qnrA, 1 qnrB, 2 qnrD and 8 qnrS, 9 aac(6')-Ib-cr, and 19 oqxAB; however, neither qepA nor qnrC were detected. Notably, 18 Klebsiella spp., harbored oqxAB, nine E. coli were positive for qnrS and two Morganella morganii yielded qnrD resistance determinant. In this study, we demonstrated 17.7% prevalence of PMQR-positive Enterobacteriaceae and first reported qnrD-resistance determinant in Hungary. Altogether, 25 PMQR-positive strains were susceptible or low-level resistant to ciprofloxacin with minimum inhibitory concentration (MIC) between 0.06 and 1 mg/L, suggesting that prevalence of PMQR determinants is underestimated and screening among clinical isolates exhibiting reduced susceptibility is necessary. Fluoroquinolone resistance breakpoints of Enterobacteriaceae were revised in 2017 by European Committee of Antimicrobial Susceptibility Testing indicating ciprofloxacin susceptibility only until 0.25 mg/L MIC value.

Entities:  

Keywords:  Enterobacteriaceae; quinolone resistance; urinary tract infection

Mesh:

Substances:

Year:  2018        PMID: 29471688     DOI: 10.1556/030.65.2018.012

Source DB:  PubMed          Journal:  Acta Microbiol Immunol Hung        ISSN: 1217-8950            Impact factor:   2.048


  5 in total

1.  Multiple Copies of qnrA1 on an IncA/C2 Plasmid Explain Enhanced Quinolone Resistance in an Escherichia coli Mutant.

Authors:  Laura Vinué; Mohamad R A Sater; Ian Herriott; Miriam H Huntley; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  Prevalence of extended spectrum beta lactamase and plasmid mediated quinolone resistant genes in strains of Klebsiella pneumonia, Morganella morganii, Leclercia adecarboxylata and Citrobacter freundii isolated from poultry in South Western Nigeria.

Authors:  Olajumoke R Akinbami; Samson Olofinsae; Funmilola A Ayeni
Journal:  PeerJ       Date:  2018-06-22       Impact factor: 2.984

3.  Extensive Drug-Resistant Salmonella enterica Isolated From Poultry and Humans: Prevalence and Molecular Determinants Behind the Co-resistance to Ciprofloxacin and Tigecycline.

Authors:  Norhan K Abd El-Aziz; Yasmine H Tartor; Rasha M A Gharieb; Ahmed M Erfan; Eman Khalifa; Mahmoud A Said; Ahmed M Ammar; Mohamed Samir
Journal:  Front Microbiol       Date:  2021-11-25       Impact factor: 5.640

4.  Diversity in the swimming motility and flagellar regulon structure of uropathogenic Morganella morganii strains.

Authors:  Leyla Minnullina; Zarina Kostennikova; Vladimir Evtugin; Yaw Akosah; Margarita Sharipova; Ayslu Mardanova
Journal:  Int Microbiol       Date:  2021-08-07       Impact factor: 2.479

5.  An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study.

Authors:  Flor Y Ramírez-Castillo; Adriana C Moreno-Flores; Francisco J Avelar-González; Francisco Márquez-Díaz; Josée Harel; Alma L Guerrero-Barrera
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-07-24       Impact factor: 3.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.